<?xml version="1.0" encoding="UTF-8"?>
<p id="p0060">Within 2Â months, a management guideline was developed and repeatedly revised based on the rapid changes and accumulation of knowledge as the situation evolved. A standard guideline is vitally important in the management of a novel viral disease that affects the human body through unknown mechanisms and for which no specific treatment or vaccine is available. More than 100 clinical trials have been approved to test various treatment options, including the highly controversial use of corticosteroids and the efficacy of the promising antiviral agent remdesivir.</p>
